Rare disease detectives: new study maps how two genetic conditions unfold in children

NCT ID NCT05050669

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study follows children aged 2 to 18 with confirmed ENPP1 deficiency or early-onset ABCC6 deficiency to understand how these rare diseases progress. Researchers will measure blood markers, check for calcification in arteries and organs, and track bone health and movement over time. No treatment is given—the goal is to gather natural history data to inform future care and research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand how these rare diseases develop and change over time, potentially guiding future treatments.
What could go wrong
This is an observational study with no treatment being tested. It will not directly improve participants' health, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOSINE TRIPHOSPHATE BINDING CASSETTE TRANSPORTER PROTEIN SUBFAMILY C MEMBER 6 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • CHOP - Roberts Center for Pediatric Research

    Philadelphia, Pennsylvania, 19146, United States

  • CHU Sainte-Justine

    Montreal, Quebec, H3T 1C5, Canada

  • Cook Children's Hospital

    Fort Worth, Texas, 76104, United States

  • Royal Manchester University Hospital

    Manchester, Manchester, M13 9WL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.